Institute of Health Law, University of Neuchâtel, 2000 Neuchâtel, Switzerland.
Med Law Rev. 2024 Nov 1;32(4):468-485. doi: 10.1093/medlaw/fwae035.
The emergence of FemTech technologies promises to revolutionize women's health and reproductive rights but conceals an insidious trap of surveillance and control in the hands of private and state actors. This article examines the extent to which FemTech technologies, under the guise of empowerment, enable private actors to play a leading role in managing reproductive rights, replacing largely inactive States in this crucial function. The analysis shows how private FemTech companies are becoming critical players in implementing and defending these rights, often in response to the inaction or inadequacies of States. The article approaches the FemTech phenomenon from several angles, including the promises of empowerment, concerns about surveillance and control, and the ambivalent roles of private actors as implementers and defenders of reproductive rights. This structure makes it possible to offer a critical analysis of the legal, societal, and ethical implications of FemTech, highlighting the tensions between the promises of empowerment and the risks of surveillance and control.
女性科技技术的出现有望彻底改变女性的健康和生殖权利,但却隐藏着一个在私人和国家行为者手中的监控和控制的阴险陷阱。本文探讨了女性科技技术在赋予权力的幌子下,在多大程度上使私人行为者能够在管理生殖权利方面发挥主导作用,取代在这一关键职能中基本不活跃的国家。分析表明,私人女性科技公司如何成为实施和捍卫这些权利的关键参与者,通常是对国家的不作为或不足的回应。本文从多个角度探讨女性科技现象,包括赋权的承诺、对监控和控制的担忧,以及私人行为者作为实施者和捍卫者的矛盾角色。这种结构使得对女性科技的法律、社会和伦理影响进行批判性分析成为可能,突出了赋权的承诺和监控和控制的风险之间的紧张关系。